Uttar Pradesh means a guarantee of safety, stability and speed: Chief Minister

CM Yogi Adityanath presented Letters of Comfort to 17 pharma companies

CM wished investors success in UP, said – your investment is linked to the trust of 25 crore people

UP now recognized for trust and timely delivery: Chief Minister

Uttar Pradesh stands with every reliable policy partner: CM

Lucknow, April 2026 : Chief Minister Yogi Adityanath on Sunday presented Letters of Comfort (LoC) to 17 pharmaceutical companies. He extended his best wishes to all investors and said the day marks a historic milestone for the state’s industrial and healthcare sectors.

He assured investors that Uttar Pradesh guarantees safety, stability, and speed, and is now being recognized for trust and timely delivery. He emphasized that the state stands firmly with every reliable policy partner.

Chief Minister Yogi Adityanath said, “Under the visionary leadership of Narendra Modi, a ‘New India’ is emerging, with the country’s economy reaching new heights. India is supplying affordable and high-quality medicines to around 200 countries.”

Referring to the recent Pharma Conclave, he said it has elevated Uttar Pradesh’s position on the global health-tech map. Addressing investors, he noted that their investment is not just in pharma and medical devices, but is also connected to the trust of 25 crore people in the state.

An investment of nearly ₹2,000 crore in research and development will help take Uttar Pradesh to new heights and is expected to generate employment for over 10,000 skilled and unskilled youth.

CM Yogi stated that the results of collective efforts are now visible on the ground, with investments creating new opportunities. Over the past nine years, due to clear policies and clean intent, Uttar Pradesh has transformed from a “BIMARU” state into the country’s growth engine. The state’s GSDP has risen to ₹36 lakh crore.

He highlighted that Uttar Pradesh is a large market with an industry-friendly environment, ample land bank, and a strong workforce. About 56% of the workforce is young, and they are being equipped with skills, innovation, and technology aligned with market needs. Currently, more than 21,000 startups are operating in the state.

CM Yogi Adityanath emphasized that law and order is the foundation of development, and since 2017, Uttar Pradesh’s strong law-and-order situation is recognized nationally and globally. The state has moved from policy paralysis to policy stability, with over 34 sectoral policies in place. Platforms like Nivesh Mitra, Nivesh Sarathi, and Udyami Mitra are facilitating a business-friendly environment.

He also outlined the changes since 2017, noting that the number of factories has increased from 14,000 to 32,000, creating large-scale employment. The state has received investment proposals worth ₹45 lakh crore so far, out of which ₹15 lakh crore has already been implemented. Another ₹7-8 lakh crore worth of proposals will soon be grounded.

Sharing UP’s success story, he said that the number of medical colleges has increased from 40 in 2017 to 83 today, each accompanied by a nursing college. The state also has two AIIMS institutions (in Gorakhpur and Raebareli) and has operationalized an AYUSH University.

A pharma park is being developed over 1,500 acres in Lalitpur, while a 350-acre medical device park is under development in Noida, with over 100 companies already associated.

Representatives of pharma companies expressed enthusiasm about investing in Uttar Pradesh and confidence that under CM Yogi Adityanath’s leadership, their investments will achieve significant growth.

Chief Minister Yogi Adityanath presented Letters of Comfort (LoC) to 17 investors. These include Biozenta Lifescience Pvt. Ltd. (₹1,250 crore in Barabanki), Romsons Medworld Pvt. Ltd. (₹136.89 crore in Noida), HiGlance Laboratories Pvt. Ltd. (₹120 crore in Noida), Kotek Healthcare (₹100 crore in Ghaziabad), JB Remedies Pvt. Ltd. (₹70 crore in Hathras/Noida), Positron Biogenics Pvt. Ltd. (₹60.24 crore in Kanpur), IV Tech Healthcare LLP (₹56.12 crore in Aligarh), JBJM Parenterals Pvt. Ltd. (₹51 crore in Lalitpur), Raspa Pharma Pvt. Ltd. (₹45.21 crore in Raebareli), NBS Group (₹42.59 crore in Sitapur), Wellness Zcure Pharmaceuticals Pvt. Ltd. (₹11.65 crore in Jalaun), Camle Industries Pvt. Ltd. (₹10 crore in Saharanpur), Radicon Laboratories Ltd. (₹10 crore in Noida), Sanjeevni Meditech Pvt. Ltd. (₹7.95 crore in Bareilly), Safecon Lifesciences Pvt. Ltd. (₹6.43 crore in Bareilly), RAP Med Surgical Products (₹5.53 crore in Hathras), and Voda Chemical Pvt. Ltd. (₹4.84 crore in Hapur).